pentoxifylline has been researched along with Spinal Muscular Atrophies of Childhood in 1 studies
Spinal Muscular Atrophies of Childhood: A group of recessive inherited diseases that feature progressive muscular atrophy and hypotonia. They are classified as type I (Werdnig-Hoffman disease), type II (intermediate form), and type III (Kugelberg-Welander disease). Type I is fatal in infancy, type II has a late infantile onset and is associated with survival into the second or third decade. Type III has its onset in childhood, and is slowly progressive. (J Med Genet 1996 Apr:33(4):281-3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araujo, Ap | 1 |
| Araujo, M | 1 |
| Swoboda, KJ | 1 |
1 other study available for pentoxifylline and Spinal Muscular Atrophies of Childhood
| Article | Year |
|---|---|
Vascular perfusion abnormalities in infants with spinal muscular atrophy.
Topics: Anti-Infective Agents, Local; Anticoagulants; Aspirin; Diosmin; Female; Fingers; Heparin; Humans; In | 2009 |